The burden of vitiligo: Patient characteristics associated with quality of life

Journal of the American Academy of Dermatology

Volumn 61, Issue 3, 2009, Pages 411-420

  Linthorst Homan, May W ^a   Spuls, Phyllis I ^a   de Korte, John ^a   Bos, Jan D ^a   Sprangers, Mirjam A ^a   van der Veen, J P Wietze ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

quality of life; SF 36; Skindex 29; vitiligo

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SKIN COLOR; SKIN PRURITUS; SOCIAL PSYCHOLOGY; VITILIGO;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; VITILIGO; YOUNG ADULT;

EID: 68849109414     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.03.022     Document Type: Article

References (41)

1. Whitton M.E., Ashcroft D.M., Barrett C.W., and Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev (2006) CD003263
2. Porter J., Beuf A.H., Nordlund J.J., and Lerner A.B. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1 (1979) 73-77
3. Kent G., and Al'Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 35 (1996) 895-898
4. Ongenae K., Beelaert L., Van G.N., and Naeyaert J.M. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol 20 (2006) 1-8
5. Grimes P.E. White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 51 Suppl (2004) S5-S7
6. Chaturvedi S.K., Singh G., and Gupta N. Stigma experience in skin disorders: an Indian perspective. Dermatol Clin 23 (2005) 635-642
7. Parsad D., Dogra S., and Kanwar A.J. Quality of life in patients with vitiligo. Health Qual Life Outcomes 1 (2003) 58
8. Njoo M.D., and Westerhof W. Vitiligo: pathogenesis and treatment. Am J Clin Dermatol 2 (2001) 167-181
9. Njoo M.D., Bossuyt P.M., and Westerhof W. Management of vitiligo: results of a questionnaire among dermatologists in The Netherlands. Int J Dermatol 38 (1999) 866-872
10. Ongenae K., Van G.N., De S.S., Vander H.Y., and Naeyaert J.M. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol 14 (2004) 177-181
11. Finlay A.Y. Quality of life assessments in dermatology. Semin Cutan Med Surg 17 (1998) 291-296
12. Finlay A.Y. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 136 (1997) 305-314
13. Kent G., and al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 21 (1996) 330-333
14. Ongenae K., Van G.N., De S.S., and Naeyaert J.M. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 152 (2005) 1165-1172
15. Borimnejad L., Parsa Y.Z., Nikbakht-Nasrabadi A., and Firooz A. Quality of life with vitiligo: comparison of male and female Muslim patients in Iran. Gender Med 3 (2006) 124-130
16. Aghaei S., Sodaifi M., Jafari P., Mazharinia N., and Finlay A.Y. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 4 (2004) 8
17. Zghal A., Zeglaoui F., Kallel L., Karmous R., Ben Ammar H., Labbane R., and Kammoun M.R. Quality of life in dermatology: Tunisian version of the Skindex-29. [French]. Tunis Med 81 (2003) 34-37
18. Belhadjali H., Amri M., Mecheri A., Doarika A., Khorchani H., Youssef M., et al. Vitiligo and quality of life: a case-control study. [French]. Ann Dermatol Venereol 134 (2007) 233-236
19. Mechri A., Amri M., Douarika A.A., li Hichem B.H., Zouari B., and Zili J. Psychiatric morbidity and quality of life in Vitiligo: a case controlled study. [French]. Tunis Med 84 (2006) 632-635
20. Parsad D., Pandhi R., Dogra S., Kanwar A.J., and Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 148 (2003) 373-374
21. Chren M.M., Lasek R.J., Quinn L.M., and Covinsky K.E. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 108 (1997) 103-107
22. De K.J., Mombers F.M., Sprangers M.A., and Bos J.D. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 138 (2002) 1221-1227
23. Aaronson N.K., Muller M., Cohen P.D., Essink-Bot M.L., Fekkes M., Sanderman R., et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 51 (1998) 1055-1068
24. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 30 (1992) 473-483
25. Chren M.M., Lasek R.J., Flocke S.A., and Zyzanski S.J. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133 (1997) 1433-1440
26. Njoo M.D., Das P.K., Bos J.D., and Westerhof W. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135 (1999) 407-413
27. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124 (1988) 869-871
28. Cohen J. Statistical power analysis for the behavioral sciences (1988), Lawrence Erlbaum Associates, Hillsdale (NJ)
29. Holm E.A., Wulf H.C., Stegmann H., and Jemec G.B. Life quality assessment among patients with atopic eczema. Br J Dermatol 154 (2006) 719-725
30. Lundberg L., Johannesson M., Silverdahl M., Hermansson C., and Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 80 (2000) 430-434
31. Shikiar R., Willian M.K., Okun M.M., Thompson C.S., and Revicki D.A. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 4 (2006) 71
32. Wahl A., Moum T., Hanestad B.R., and Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res 8 (1999) 319-326
33. Wahl A., Hanestad B.R., Wiklund I., and Moum T. Coping and quality of life in patients with psoriasis. Qual Life Res 8 (1999) 427-433
34. Wallenhammar L.M., Nyfjall M., Lindberg M., and Meding B. Health-related quality of life and hand eczema-a comparison of two instruments, including factor analysis. J Invest Dermatol 122 (2004) 1381-1389
35. Sampogna F., Picardi A., Chren M.M., Melchi C.F., Pasquini P., Masini C., and Abeni D. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 66 (2004) 620-624
36. Fowler J.F., Ghosh A., Sung J., Emani S., Chang J., Den E., et al. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol 54 (2006) 448-457
37. Lasek R.J., and Chren M.M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 134 (1998) 454-458
38. Jones-Caballero M., Chren M.M., Soler B., Pedrosa E., and Penas P.F. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol 21 (2007) 219-226
39. Porter J.R., and Beuf A.H. Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 32 (1991) 192-204
40. Schmid-Ott G., Kunsebeck H.W., Jecht E., Shimshoni R., Lazaroff I., Schallmayer S., et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol 21 (2007) 456-461
41. Rumpf H.J., Lontz W., and Uesseler S. A self-administered version of a brief measure of suffering: first aspects of validity. Psychother Psychosom 73 (2004) 53-56